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ABSTRACT OF THE DISSERTATION 
MAGNETOELECTRIC NANOPARTICLES: PARADIGM SHIFT IN 
BIOMOLECULAR DIAGNOSTIC 
by 
Chooda M. Khanal 
Florida International University, 2016 
Miami, Florida 
Professor Sakhrat Khizroev, Major Professor 
Recently discovered multiferroic nanoparticles (MFNs) known as magnetoelectric 
nanoparticles (MENs) promise to revolutionize next-generation biomedical diagnostic 
techniques and enable rapid and cost-effective screening of lethal diseases. Due to the 
quantum-mechanically caused intrinsic magnetoelectric (ME) effect, these nanoparticles 
display strongly coupled magnetic and electric moments and thus provide a unique 
pathway to monitor and optionally control intrinsic characteristics of bio organisms via 
application of external magnetic fields. Due to the ME effect, when placed in the 
microenvironment of a biomolecular sample, MENs’ magnetic properties change to reflect 
the molecular nature of the sample. Such an unprecedented intrinsic connection to cells 
and microorganism’s intrinsic characteristics can pave a way to a new diagnostic paradigm.  
A novel concept of portable biomolecular screening device based on continuous 
wave nuclear magnetic resonance is being studied to identify microorganisms like bacteria, 
virus and cancer cell lines. For the first time, MENs have been used to modify NMR spectra 
and thus enable identification of different cancer cell lines from each other as well as from 
 vii 
 
their normal counterparts at the sub-cellular level. This approach can be used for both in 
vitro and in vivo diagnostics. In addition, blood samples of Pulmonary Arterial 
Hypertension (PAH) patients with severe heart and lung conditions were used to study the 
activity of MENs with prothrombin, the clotting factor of the blood. MENs has significant 
interaction with prothrombin. MENS can be used for diagnostics of several diseases 
associated with blood and cancer and it may be used as a therapeutic agent. The experiment 
proved that the MENs are safe and nontoxic carriers of therapeutic drugs.   
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1. INTRODUCTION 
1.1 Bio-magnetoelectronics 
A recently discovered class of multiferroic nanoparticles (MFNs) known as 
magnetoelectric nanoparticles (MENs) have potential to become useful tools for diagnosis, 
screening and targeted drug delivery in the near future [1-6]. These particles, which are not 
only electrically polarizable or magnetically polarizable but also exhibit both properties at 
the same time, are naturally designed to exploit the intrinsic characteristics of bio 
organisms. Due to the quantum-mechanical origin of their magnetoelectric (ME) coupling, 
these nanoparticles display strongly coupled magnetic and electric moments and thus 
provide a unique pathway to monitor and optionally control intrinsic characteristics of bio 
organisms via the application of external magnetic fields. The ME coupling of MENs 
surface-conjugated with a biomolecular sample strongly depends on the molecular nature 
of the sample and thus opens the door to a new diagnostic paradigm.  
For the first time, this project is dedicated to exploiting the unique properties of 
multifunctional nanoparticles for rapid screening and unprecedented diagnostic of 
microorganisms and cells at the molecular level.  
1.2 Background 
Rapid and accurate identification of microorganisms, including bacteria and viruses, 
is critical for improving the state of care of infectious diseases. A lack of rapid 
identification and therapeutics, for example, allowed the 2014 Ebola outbreak to be one of 
the most widely spread and persistent epidemics in recent times [7]. Recently developed 
lab-on-a-chip technology that can detect the traces of Ebola virus has made it possible for 
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rapid diagnostics and testing in the field, although it still requires testing in a special 
biosafety facility due to the highly infectious nature of the virus [8]. Despite the world’s 
focus on the Zika virus, it has not decimated spreading across the nations, thanks to the 
slow and limited screening procedures [9-11].  Last but not least, the importance of the 
ability to rapidly screen cell cultures for different cancers and identification of cancer at 
the sub-cellular level is hard to overestimate especially today when cancer is number one 
cause of death. The traditional screening approach is to use bacterial culture and 
biochemical staining [12-18]. This technique, unfortunately, requires a tedious sample 
preparation protocol and is relatively slow (a matter of hours and sometimes days), and is 
limited to a few biomarkers. On a positive side, an advanced approach based on polymerase 
chain reaction (PCR) is exorbitant to be used in most clinics and small office environments 
[19,20].  
In addition, it is imperative to understand the functionality of proteins in our body 
that play a vital role for disease prevention and cure. There are many applications of 
nanotechnology in computer engineering, sensing, biology and medicine, pathogen 
detection etc.; however, not much has been done regarding the identification of diseases at 
the cellular or even molecular level [2-4,21-25]. Most of the modern nanomedicine 
development relates to drug delivery through blood vessels; the toxicity of nanoparticles 
has been discussed but very little has been done to understand the effect of nanoparticles 
on the blood coagulation system [26-29].  We attempt to give a new angle to nanoparticles 
from the perspective of diagnostics at the cellular level. We use MENs to distinguish 
various cancer cells from each other and from their normal counterparts, obtain the 
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signature of prothrombin and its functionality using magnetoelectric nanoparticles, and 
consider other applications. 
Our group has for the first time designed and investigated a device for sensitive and 
rapid screening for various biological entities such as bacteria, viruses, cancer cells, and 
other biomolecular structures. Over the past several years, we concocted this device on the 
principle of a small package and low-cost in order to make it readily available even in the 
poorest healthcare facilities. This device is based on continuous wave nuclear magnetic 
resonance (NMR) technology. 
1.3 Motivation and Purpose 
Infectious diseases caused by bacteria and viruses continue to exact a substantial toll 
on health and health care resources in the USA and globally. Despite success in some areas 
of disease treatment, a lack of reliable and rapid screening of such microorganisms 
continue to challenge prevention and control of disease persistence [30].  
Recently there has been increased interest in magnetic nanoparticle bio-sensing 
(MNB) [31-33].  Due to the new dimensionality provided by the presence of externally-
controlled magnetic moments, MNB promises to enable high-specificity screening and fast 
diagnostic of pathogens.  Indeed, ideally one could envision an apparatus in which 
magnetic nanoparticles are used to connect the intrinsic information with regards to single 
cells, e.g. the electric charge profile on the surface of a cell emerged in a specific biological 
microenvironment (media), to external devices which can adequately process the magnetic 
information, e.g. nuclear magnetic resonance (NMR), magnetic resonance imaging (MRI), 
magnetic particle imaging (MPI), vibrating sample magnetometry (VSM), B-H looper for 
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susceptibility measurements, magneto-optical Kerr microscopy, magnetic force 
microscopy (MFM), and others [34-36].  
The other motivation of this dissertation is to maximize the drug delivery capabilities 
of the same nanoparticles used for screening. Studying the above diagnostic application 
involves deep understanding of mechanisms of the molecular interaction between 
nanoparticles and the microorganisms at the sub-cellular level and development of ways to 
control these intrinsic mechanisms. The knowledge obtained through this study is critical 
also for improving the more popular drug delivery applications of nanoparticles.  For 
example, this knowledge will help achieve full payload carrying capacity and delivery of 
the fully loaded cargo in a manner where release close to 100% of the therapeutic drug is 
released on site and on-demand [2-4,37,38]. In modern drug delivery approaches, 
therapeutic drugs are attached to nanoparticles via covalent, non-covalent (electrostatic, 
Van der Waal, hydrogen), or ionic bonds. Modifying the surface properties (i.e. by 
controlling the surface charge and polarity) of the nanoparticles and their functionalization 
plays a key role in improving the attachment of the drug.  Such goals are also being pursued 
in this particular study.  
Most of the current nanoparticle based drug delivery systems are relatively inefficient 
due to their strong dependence on the intrinsic properties of the cell’s physiological 
conditions such as temperature, pH, enzymatic reactions, and others to deliver the cargo 
drug. As a result, the drug releasing process is extremely inefficient due to the dependence 
on the minute changes in the physiological conditions in the microenvironment of the cell. 
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Using MENs instead of the traditional nanoparticles can overcome this roadblock because 
MENs provide an additional dimension to control delivery and release of the drug. 
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2.  MAGNETOELECTRIC NANOPARTICLES 
2.1 What is magnetoelectric nanoparticles 
Multiferroic nanoparticles (MFNs), which sometimes include the category of 
particles called magneto-electric nanoparticles (MENs), simultaneously show the 
properties of ferromagnetism and ferroelectricity. These MEN particles are magnetically 
as well as electrically polarizable and show all the properties- ferromagnetic, ferroelectric, 
multiferroic, and magnetoelectric. MFMs exhibits a strong quantum coupling of magnetic 
and electric properties and come under the multiferroic category, as they demonstrate both 
ferroelectric and ferromagnetic properties simultaneously [1,5,6].  
Figure 1 shows the relationship between the magneto-electric and multiferroic 
materials. Borocite (Ni3B7O13I) was the first material reported to exhibit magneto-electric 
switching below 60 K [39]. Magnetoelectric effect in composite materials is the product 
tensor property given by the product of magnetostrictive effect (magnetic/ mechanical 
effect) in the magnetic phase and the piezoelectric effect (mechanical/ electrical effect) in 
the ferroelectric phase [40]. Magnetic to electric energy conversion exploits the advantages 
of properties from two different phases of the material, i.e. from the ferromagnetic phase, 
piezomagnetic or magnetostrictive property and from the ferroelectric phase, piezoelectric 
or electrostrictive property. Thus, when an external magnetic field (ΔH) is applied, 
magnetostrictive stress formed in the magnetic phase is transferred to the ferroelectric 
phase changing the polarization (ΔP) and the associated electric field (ΔE) due to the 
piezoelectric effect. Performance of magnetoelectric materials is determined by this 
transfer efficiency, which is referred to as the magneto-electric coefficient (α = ΔP / ΔH) 
or as the magneto-electric voltage coefficient (αE = ΔE / ΔH). Magneto-electric coefficients 
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of various multiferroic materials are shown in Table 1. Electric flux density (D) in 
multiferroic materials as shown in the following equation is determined by the magneto-
electric coefficient tensor (αij), permittivity tensor (εij), and the piezoelectric coefficients 
(eij) in an applied vector magnetic, electric field, and external stress S [1,41].  
𝐷𝑖 = ∑ 𝜀𝑖𝑗𝐸𝑗
𝑗−3
𝑗−1
+ ∑ 𝑒𝑖𝑗𝑆𝑗
𝑗−6
𝑗−1
+ ∑ 𝛼𝑖𝑗𝐻𝑗
𝑗−3
𝑗−1
 
 
Figure 1: The relationship between the magneto-electric and multiferroic materials. 
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Morphology Materials 
ME 
coefficient 
Ref 
Composite BaTiO3 and CoFe2O4 50 [42] 
Composite Terfenol-D and PZT in polymer matrix 42 [43] 
Laminated 
composites 
Terfenol-D in polymer matrix/PZT in polymer 
matrix 
3,000 [44] 
Laminate Terfenol-D/PZT 4,800 [45] 
Laminate La0.7Sr0.3MnO3/PZT 60 [46] 
Laminate NiFe2O4/PZT 1,400 [46] 
Table 1: Magneto-electric coefficients in two-phase systems. 
Magnetoelectric materials can be used in two forms, i.e. either in the laminate form 
or in the particulate form. Using magnetoelectric materials in the particulate form is often 
the better option because of the excellent magneto-electric properties caused by the 
following reasons: 
a. Shape effects: spherical shape of the particles provides better transfer of 
magnetostrictive stress from magnetic phase to the ferroelectric phase. 
b. Zero-substrate clamping effect: laminates/films needs to be clamped, which 
restricts the magnetostrictive strains. 
c. Binding efficiency: mechanical contact in the interface of particulate 
composites is much higher as compared to the laminate/films composites. 
(Note: laminate/films composites need to be either glued or sintered which 
often results in poor binding efficacies). 
So far, magnetoelectric materials are extensively used in microwave filters, signal 
amplification devices, data storage devices, transducers, optical-diodes, power generation 
systems, high frequency switches, miniature-antennas, and spintronics [47-54], but in this 
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dissertation, we present the biomedical applications of the magnetoelectric materials 
especially the application of detection of microorganisms.  
MENs, also called “smart” nanoparticles, can controllably regenerate important 
physical functions on the surface of the cellular microorganism being tested. The MEN’s 
underlying physics is a very intricate quantum-mechanical coupling between magneto-
electric spinel and ferromagnetic perovskite structures. This coupling allows the use of 
external magnetic fields to control local electric fields for sub-cellular diagnostic and 
targeted drug delivery into specific cells [55,56].  
2.2 Novelty and significance of the proposed nanotechnology 
Due to the new dimensionality provided by the presence of externally-controlled 
magnetic moments, in magnetic nanoparticles, we have the capability to enable high-
specificity screening and fast diagnostic of pathogens.  Indeed, ideally one could envision 
an apparatus in which magnetic nanoparticles are used to connect the intrinsic information 
with regards to single cells, e.g. the electric charge profile on the surface of a cell emerged 
in a specific biological microenvironment (media), to external devices which can 
adequately process the magnetic information, however, the current progress in the area of 
novel technologies is still relatively slow.  The challenge is to “connect” magnetic 
nanoparticles to the intrinsic information at the cellular or intra-cellular level.  The 
fundamental nature of this intrinsic information is reflected in its electric-field 
characteristic; all of the previously mentioned microorganisms and cell structures have 
signature surface proteins/receptors which are inclined to be electrically polarized in a 
certain biological microenvironment and which are also the main binding sites for 
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nanoparticles. The charge on different cell surfaces does not only differ by its amount but 
also by its distribution.  Unfortunately, it is difficult to measure this information directly 
using electric fields alone because electric fields experience significant interference when 
they go through the media and as a result direct physical contacts would be required, which 
then makes the measurements both difficult and costly.  In addition, the traditional 
approach of using nanoparticles for bio-sensing and as a drug delivery platform lacks the 
sufficient targeted delivery in a controlled environment application. Therefore, to 
overcome all the above challenges associated with the traditional magnetic nanoparticles, 
we have chosen to exploit MENs. 
MENs can be used to enable externally controlled passive targeted delivery and 
release of therapeutic loads, e.g. specific peptides for regulating cell proliferation with high 
selectivity. Unlike modern active-targeting nanotechnology approaches, e.g. antibody- or 
ligand mediated therapies that interact with the immune system, MENs do not rely on the 
immune system to target the diseased cells. Instead, MENs use a physical force that is 
driven by the Coulomb interaction, which is self-triggered when the nanoparticles circulate 
past the targeted cells with a specific electric-field signature. This self-triggering 
mechanism can be either “pre-programmed” via defining the MENs saturation 
magnetization and the ME coefficient through a fabrication process or via application of 
an external magnetic field. Unlike conventional passive targeting, like enhanced 
permeability and retention (EPR), MENs do not need relatively large cell aggregates for 
targeting [57,58]. MENs-driven passive targeting is achieved at the cellular level through 
detection of specific stray electric field profiles. 
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The drug-loaded MENs cross the membrane through field induced “nano-
electroporation” and release their load on demand. We proved our novel technique to show 
that the anti-cancer drug loaded in our smart particles penetrated through the membrane 
and completely eradicated tumor cells within 24 hours without affecting the normal cells 
[2,4]. We have also demonstrated the externally controlled on-demand release of anti-HIV 
drug using our smart nanoparticles as carriers [3].  
Moreover, the fact that each cell possesses a unique intrinsic electric characteristic, 
MENs may also be used as magneto-electronic biomarker. Some cancer cannot be treated 
completely and also passes from generation to generation. The most common cause of 
treatment failure in acute lymphoblastic leukemia (ALL) remains relapse, occurring in 
approximately 15 to 20 percentage of patients [59-61]. In other words, a child with ALL 
may seem to be cured completely with chemotherapy treatment however about 15 to 20 
percentage of the time it appears again during adulthood. The cancerous traces hidden in 
brain or sometimes in testicles (testicular relapse in male) cannot be treated by the 
conventional chemotherapy and remains unknown for years. There is no other way of 
finding out if the cancerous traces are still there in the body after treatment. So, exploiting 
the electric property of such cells with the MENs as a magneto-electronic biomarker may 
lead to the path of diagnosis and targeted therapy of such diseases.  
Before we proceed, once again we would like to stress the importance of not 
confusing MENs with traditional magnetic nanoparticles (MNs) and the novelty and 
significance of proposed nanotechnology based on MENs. One of the importance of MENs 
over the traditional magnetic nanoparticles (MNs) is shown in Figure 3. MENs were 30-
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nm coreshell CoFe2O4@BaTiO3 nanostructures consisting of the ferrimagnetic spinel core 
CoFe2O4 and the piezoelectric perovskite shell BaTiO3. MNPs were 20-nm CoFe2O4 
ferrimagnetic nanostructures. 
Following is the M-H characteristics and blocking temperature measurement plot 
using vibrating sample magnetometer physical property measurement system (PPMS). A 
room-temperature Lakeshore vibrating sample magnetometer (VSM) with a 3-T magnetic 
field sweep was used to measure key magnetic properties of nanoparticles under study 
including the magnetization saturation and the magnetic coercivity. A cryogenic VSM 
Quantum Design PPMS with a 9-T superconducting magnet was used to measured M-H 
temperatures in a wide temperature range, from 4K to over 300K.  
 
 
Figure 2. (a) M-H hysteresis loops for 30-nm MENs measured in a wide temperature range 
from 4 to 300 K. The inset shows A TEM image showing a coreshell structure of 30-nm MENs. 
b) Blocking temperature measurement curves including zero-field cooling (ZFC), field 
cooling (FC) and field warming (FM) curves at a field of 100 Oe.  
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Figure 3: (a) and (b) show M-H hysteresis loops of 30-nm MENs and traditional 20-nm 
magnetic nanoparticles (MNs) without any ME effect, respectively, measured via vibrating 
sample magnetometry (VSM).  
 
To understand the MENs’ temperature dependence, typical M-H hysteresis loops 
of MENs in a temperature range from 4 to 300 K obtained via a cryogenic vibrating sample 
magnetometer Quantum Design PPMS are shown in Figure 2(a). The standard 
magnetization versus temperature curves under zero field cooling (ZFC) and non-zero field 
cooling (FC) conditions to determine the blocking temperature are shown in Figure 2(b). 
The blocking temperature is the temperature above which the nanoparticles become 
superparamagnetic. In this case, it is above 300 K, which confirms that the nanoparticles 
are not superparamagnetic at room temperature despite their small size. The ME 
coefficient, α, for these nanostructures is known to be in the range from 10 to over 100 mV 
cm-1 Oe-1. 
From the loops in Figure 3, one can see that MENs and MNs have saturation 
magnetizations of approximately 1 and 40 emu/g, respectively, and coercivity fields of 
approximately 310 and 90 Oe, respectively.   
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2.3 Preparing magnetoelectric nanoparticles  
2.3.1 Magnetoelectric nanoparticles (Core) 
 CoFe2O4 particles (core) were prepared by the standard hydrothermal method 
[2,62]. 0.58 grams of Cobalt Nitrate (Hexahydrate) reagent [Co(NO3)2.6H20] and 1.6 grams 
of ferric nitrate [Fe(NO3)3.9H20] were dissolved in 150 milliliters of distilled water taken 
in a beaker. In a second beaker 2 grams of polyvinylpyrrolidone and 9 grams of sodium 
borohydride were dissolved in 50 ml of distilled water. The two aqueous solutions were 
mixed by gently adding drop by drop from the second beaker to the first one using pipette 
and continuously stirring at 320 rpm and then 1000 rpm. During this process, the beaker 
was placed in a heater at 70°C. After the solution is completely incorporated, the stirrer 
was set to 300 rpm and the temperature was set to 90°C for overnight (12 hours). Similar 
procedures for the preparation of core are implemented in the Personalized Nanomedicine 
lab at FIU for previously published journals [2-4]. 
2.3.2 Precursor solution 
 To prepare the precursor solution of BaTiO3, two beakers were taken. 150 mL of 
ethanol was mixed with 5 grams of citric acid and 240 uL of titanium (IV) ispropoxide in 
the first beaker. 1 gram of citric acid and 0.145 gram of barium carbonate was dissolved in 
the second beaker containing 150 mL of deionized (DI) water. The two solutions were 
mixed and sonicated for 60 minutes. 
  Coreshell CoFe2O4-BaTiO3 multiferroic nanoparticles were prepared by mixing 0.5 
g of CoFe2O4 nanoparticles core in the BaTiO3 precursor solution and the mixture was 
sonicated for 2 hours.  Once the CoFe2O4 nanoparticles were thoroughly dispersed, the 
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mixture was dried on the hot plate at 70°C overnight while continuously stirring.  The 
obtained polymer precursor was subjected to 500°C (for 10nm), 600°C (for 30 nm), 700°C 
(for 100nm) for 5 hours in a furnace (CMF-1100).  
The prepared samples were imazed for the size verification. We used scanning 
probe miscroscopy, Transmission Electron Microscopy (TEM) [63] and Atomic Force 
Microscopy (AFM) [64]. All the samples were verified before use. TEM is an imaging 
technique where a beam of electrons is transmitted through a sample interacting with it as 
it passes through it. The image is formed by the interaction of the beams with the sample, 
details explained elsewhere [63]. Figure 4 is an image of a 30 nm sample taken by TEM. 
It clearly shows the two-phase core shell nature of MFMs. The scale bar is 100 nm. 
Similarly, we took TEM images of 10 nm and 100 nm nano particles as well (not shown 
here). 
 
Figure 4: Transmission Electron Microscopy (TEM) image showing the two-phase core-
shell nature of 30 nm MENs. 
100 nm 
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The Atomic Force Microscope cannot show the two phase shell due to its different 
nature of imaging. The image is taken by feeling or touching the surface of the sample my 
its mechanical probe, and not by transmitting through the sample as in TEM. AFM takes 
an image by the reaction of the probe to the forces that the sample imposes on it as the tip 
of AFM runs across the surface of the sample that can be used to form an image of the 
three-dimensional shape (topography) of a sample surface at a high resolution. It can show 
the size of the particles in nanometer scale. Figure 5 and Figure 6 are the screen shot images 
of 10 nm and 100 nm respectively taken my AFM. 
 
 
Figure 5: Screen shot of AFM image of 10 nm nano-particles. 
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Figure 6: Screen shot of AFM image of 100 nm nano-particles. 
 
The radius of curvature of AFM tip is on the order of 10 nm, so there is always an 
additional margin of about 20 nm on the horizontal distance of the sample. For example, 
Figure 4 shows an image of 100-nm nanoparticles. The curser is placed at the two 
extremities of the particle and the horizontal distance shows about 130 nm. The average 
size of the particles is 100 nm. Similarly, Figure 3 is an image of 10 nm particles. The 
curser is placed at one edge and the center of the particle to measure the vertical distance 
of the particle rather than the horizontal distance. If the particle size is on the order of the 
radius of curvature of the tips, it is better to take the vertical distance to measure the particle 
size.  Due to the difference in vertical and horizontal positioning approaches, the vertical 
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distance and each of the two horizontal distances are measured with precisions of 
approximately 1 and 10 nm, respectively.  
2.3.3  Coating of intermediate layer 
Due to the ultra-fine size of MENs and the low toxicity, they are promising 
candidates for medical applications.  However, since the medicated particles are 
transported via blood, their sizes, surface charge and ME chemistry strongly affects the 
bioavailability of the particles inside the body. Not to mention that under some cases, if not 
properly treated and/or functionalized, the nanoparticles may become toxic and may not 
properly function for the desired external magnetic field for targeted delivery. Specific 
experiments require controllable dissociation of drug molecules from the nanoparticle 
surface by selecting appropriate intermediate layers, such as Glycerol monooleate (GMO), 
Tween-20, or Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). In our experiment 
we used a 2 nm of the intermediate layers of GMO and EDC. 
In both cases (to coat with GMO and EDC, respectively), as the first step 20 mg of 
MENs were added to phosphate-buffered saline (PBS) buffer solution. Then, 40 uL of 
GMO solution (1 mg/ml) was added to the solution and incubated for an hour while slowly 
rotating to achieve uniform coatings. After completing the incubation process, the particles 
were washed by centrifuging to 33,000 revolutions per minute (rpm) for 5 minutes. After 
spinning, any GMO bubbles and PBS were removed gently. PBS was added again to the 
sediments, vortexed, and centrifuged again to 40,000 rpm for 5 minutes. The washing 
process was repeated 3 to 4 times until all unbounded GMO was completely removed from 
the solution. 
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We used Energy Dispersion Spectroscopy (EDS), an analytical technique used for 
the elemental analysis or chemical characterization of a sample. Phillips CM-200 200 kV 
Transmission Electron Microscope (TEM) with Energy Dispersive Spectroscopy (EDS) 
option was used to obtain TEM images and EDS profiles. Figure 7 shows the composition 
of MENs and Figure 8 depicts the composition of GMO coated nanoparticles.  
 
 
Figure 7: Energy dispersion spectroscopy (EDS) results depict the composition of 
magnetoelectric nanoparticles. 
 
 20 
 
 
Figure 8: Energy Dispersion Spectroscopy (EDS) results depict the composition of GMO 
coated magnetoelectric nanoparticles. 
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3. DEVICE PRINCIPLE AND DESIGN 
3.1  Background 
We designed a nanodevice for rapid screening and signature identification of cells 
and other microorganisms. We investigated the invention on cancer cells, different 
bacteria, viruses, prothrombin and other biomolecular structures over the course of several 
years. The principle of this cost effective and small package format device is based on 
continuous wave nuclear magnetic resonance (NMR) technology. NMR is a physical 
phenomenon in which nuclei in a magnetic field absorb and re-emit electromagnetic 
radiation. The energy is at a specific resonance frequency which depends on the strength 
of the magnetic field and the magnetic properties of the atoms. Protons and neutrons inside 
the nucleus of an element possess a magnetic dipole moment () which is similarly 
characterized by an intrinsic spin quantum number like an electron spin. If a nucleus has 
an even number of nuclei for example 12C6, which has 6 protons and 6 neutrons, these spins 
are paired against each other summing to zero overall spin or magnetic dipole moment. 
However, in nuclei like 1H1 and 
19F9, the nucleus does not possess a net zero spin, so these 
nuclei have a finite magnetic dipole moment. 
It is commonly recognized that sensitive and rapid identification of blood cells and 
microorganisms including bacteria and viruses is critical for improving the state of care of 
infectious diseases. The traditional approach is to use bacterial culture and biochemical 
staining. Unfortunately, this technique requires a tedious sample preparation procedure and 
is thus relatively slow (a matter of hours and sometimes days), and, not to mention, is 
limited to a few notable biomarkers. A more advanced approach based on polymerase chain 
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reaction (PCR) remains cost-ineffective for being used in most clinics and small office 
environments.  
Therefore, there has recently been increased interest in magnetic nanoparticle bio-
sensing (MNB). Due to the new dimensionality provided by the presence of externally-
controlled magnetic moments, MNB promises to enable high-specificity screening and fast 
diagnostic of pathogens.  Indeed, ideally one could envision an apparatus in which 
magnetic nanoparticles are used to connect the intrinsic information with regards to single 
cells, e.g. the electric charge profile on the surface of a cell located in a specific biological 
microenvironment (media), to external devices which can then adequately process the 
magnetic information, e.g. nuclear magnetic resonance (NMR), magnetic resonance 
imaging (MRI), magnetic particle imaging (MPI), vibrating sample magnetometry (VSM), 
B-H looper for susceptibility measurements, magneto-optical Kerr microscopy, magnetic 
force microscopy (MFM), and others [31-36]. 
However, the current progress in the area of novel technologies is still relatively 
slow.  The challenge is to “connect” magnetic nanoparticles to the intrinsic information at 
the cellular or intra-cellular level.  The fundamental nature of this intrinsic information is 
reflected in its electric-field characteristic; all the previously mentioned microorganisms 
and cell structures have signature surface marker proteins and receptors which are inclined 
to be electrically polarized in a certain biological microenvironment and which are also the 
main binding sites for nanoparticles. The charge on different cell surfaces does not only 
differ by its amount but also by its distribution.  Unfortunately, it is difficult to measure 
this information directly using electric fields alone because electric fields experience 
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significant interference when they go through the media and as a result direct physical 
contacts would be required, which makes the measurements difficult and costly. 
 Therefore, the underlying physics of our invention relies on using magnetoelectric 
nanoparticles (MENs) to convert the electric charge information stored on the cell surface 
into a certain magnetic field pattern which could be quickly measured by external magnetic 
measurement setups such as NMR, VSM, MOKE magnetometry, B-H looper, or others. 
3.2  Device Principle 
The first embodiment would be in the form of a rapid NMR sweeper (it can be 
frequency or magnetic field sweep). The schematic in Figure 9 is not to scale but illustrates 
the basic components of the setup. The entire prototype apparatus in the lab is quite portable 
and would easily fit in a regular backpack.  A more advanced embodiment would consist 
of a miniaturized battery-supplied integrated circuit chip, which could be purchased in a 
neighborhood pharmacy store. In the future, such an integrated chip for rapid bacteria/virus 
identification could be carried in a pocket or attached to everyday clothing; the chip would 
be wirelessly connected to a computing device such as a smart phone, watch, laptop, or 
another, which in turn would provide the constantly updated database of spectra for 
different bacteria and viruses; such a database could be shared through the internet. 
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Figure 9: A basic device implementation for rapid screening of bacteria, viruses, and other 
cellular microorganisms.  
 
The current device is quite portable in that it will fit inside a regular bag or 
backpack. A future device implementation would be in the form of an integrated microchip, 
which could be carried in a pocket or integrated in everyday clothing. In this case, a patient 
sample under study would optionally emerged be integrated into a special media, with the 
nanoparticles uniformly distributed in the media, to enhance the charge accumulation on 
specific surface sites characteristic of the sample. For example, in case of a virus, it could 
be put in a special stabilizing solution (which would also preserve the integrity of the 
sample) with a neutral physiological pH, such as Tris-EDTA buffer solution, PBS, or 
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another, to enhance the charge presence at low-dimensional irregularities (protruding 
proteins, receptors, etc.) on its surface where the charge would be more strongly 
accumulated (localized) to reflect the signature characteristics of this particular virus 
(Figure 10).   
  
Figure 10: Schematic illustration of a HIV virus with characteristic protruding proteins/ 
receptors. Nanoparticles bind to these proteins.  
 
As the nanoparticles bind to the characteristic surface sites, the nanoparticles are 
subjected to local electric fields due to the signature charge accumulations. Because of the 
unique magnetoelectric (ME) coefficient, these local electric fields generate local magnetic 
fields, which in turn superimpose with the magnetic field generated by the NMR setup. 
The NMR signal, i.e. the electromagnetic energy absorption, is generated when the 
resonance condition, ℎ𝑣 = 𝑀𝑛𝐻𝑛𝑒𝑡 is satisfied, where h is the Plank constant, v is the 
frequency of the electromagnetic wave (usually in kHz range in the NMR setup), Mn is the 
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nuclear spin measured in NMR (usually, proton spin), Hnet is the net magnetic field.  This 
local net field is made of the two contributions, (i) the external field generated by the NMR 
magnets, H0, and contribution due to the ME effect of MENs on the surface of the virus, 
HME, respectively: 𝐻𝑛𝑒𝑡 = 𝐻0+ 𝐻𝑀𝐸. 
As a result, each NMR spectrum will reflect the surface charge contribution of 
specific cells.  Examples using bacteria, virus, and blood cells are presented in the 
proceeding chapters.  
To confirm the underlying mechanism of the nanoparticles binding to specific sites 
on viral and bacterial surfaces, the following atomic force microscopy (AFM) experiments 
were conducted with several different strains of bacteria (Figure 12 through 15).  AFM 
directly measures the surface topography with a nanometer spatial resolution.  It could be 
mentioned that the viral surfaces display even more pronounced differences and therefore 
would result in a more significant effect. However, for the sake of simplicity, we first 
focused on the bacteria, which were currently available in our laboratory.   
The respective NMR spectra measured for different bacteria strains are shown in 
Chapter 4.  Two embodiments of MENs, uncoated nanoparticles, and nanoparticles 
functionalized with a thin layer glycerol monooleate (GMO), respectively, are shown.  
As embodiment complementary application, the setup can be used to identify 
different cell types, including normal and cancer cells of the same or different types at 
different cancer progression stages. The physical origin of the charge accumulation on the 
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surface is somewhat different between viruses and cells since viruses lack sophisticated 
membrane structure like that found on cells. In addition to the preferred binding sites due 
to specific proteins/receptors/etc., the accumulated charge strongly depends on the electric 
charge capacity of the cell membrane. For example, the charge stored on the cancer cell 
membrane is significantly smaller than that on the normal cell membrane of identical type. 
Additionally, the capacity depends on the cancer progression stage.  Therefore, the charge 
contribution of the cell membrane is complex and made of several components. 
 
 
Figure 11: Spectra of normal cell line (red), cancer cell line f7 (black) and t47 (green) 
 
As an example, we used our biosensing technology to measure the spectra of three 
cell lines including a normal cell line (red line 12a) and two cancer cell lines f7 and t47 at 
different progression stages, as shown in Figure 11. Clearly, the spectrum for the normal 
cell line has a distinctly different parabolic dependence compared to the cancer cell lines. 
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In turn, the two cancer cell lines are different quantitatively. Experimental design and 
measurement is described in detail in Chapter 5. 
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4. SIGNATURE IDENTIFICATION OF BACTERIAL SAMPLE  
4.1 Background 
Rapid and accurate identification of microorganisms like bacteria is critical for 
improving the state of care of infectious diseases. Lack of rapid identification and 
therapeutics of bacterial infection epidemics has a significant growth in recent times. As 
described in chapter 1.2, recently developed lab-on-a-chip technology that can detect the 
traces of certain bacteria and viruses has made it possible for rapid diagnostics and testing 
in the field, although it still requires testing in a special biosafety facility. The traditional 
screening approach is to use bacterial culture and biochemical staining. This technique, 
unfortunately, requires a tedious sample preparation protocol and is relatively slow (a 
matter of hours and sometimes days), and is limited to a few biomarkers. On its north, an 
advanced approach based on polymerase chain reaction (PCR) is exorbitant to be used in 
the most clinics and small office environments. In order to solve the problem, our group 
has designed and investigated a device as, described in chapter 3, for sensitive and rapid 
screening for various biological entities such as bacteria, viruses, cancer cells, and other 
biomolecular structures. Over the past several years, we concocted this device on the 
principle of a small package and low-cost in order to make it readily available even in the 
poorest healthcare facilities. This device is based on continuous wave nuclear magnetic 
resonance (NMR) technology. 
4.2 Sample preparation 
First, we used bacterial samples to get establish their signature signals using NMR. LB 
media plates were streaked with frozen culture stock and incubated overnight. Single 
colony inoculated LB media was incubated overnight on a shaker. Cells were washed with 
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and resuspended in saline. Optical density was adjusted and normalized with saline to 
achieve an OD600 of 1x or 3x. Bacteria was incubated with MENs for 30 minutes at room 
temperature on a rotator. Specific amounts used for each experiment are listed beside 
results. Samples were prepared in triplicates. We used TEL cws 12-50 Advanced 
NMR/ESR System and its accompanying software to sweep the field or the frequency. 
Glass capillary tubes delivered the solution into the reader. The B0 was initially adjusted 
with a MENs only solution before any measurements were taken, and was also periodically 
adjusted as needed to mitigate expected shift in between readings. The graphs presented 
are averages of the 3 samples used. 
A triplicate of each Pseudomonas aeruginosa, Escherichia coli, Serratia 
marcescens, and Bacillus cereus was used for each experiment and the same samples were 
used for to prepare slides for Atomic Force Microscope (AFM) and Scanning Electron 
Microscope (SEM) imaging. These bacterial strains were selected to demonstrate a variety 
of possible pathogens that could be detected with this system. 
The AFM images shown in Figure 12 through Figure 15 shows the surface 
morphology of pseudomonas aeruginosa, escherichia coli, serratia marcescens, and 
bacillus cereus respectively. Top two figures are images of samples without nanoparticles 
while the bottom two are with particles. The left side images are the height maps whereas 
the right ones are the amplitude. The height maps on the left do not really look like the real 
bacteria as it appeared in the SEM images and such images do not display  
easily the shape of the features. Ways around this include shading the image, and more 
commonly, creating a pseudo-3D image from the height data. However, the deflection (or 
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amplitude) images are equivalent to a map of the slope of the sample, so they often display 
the shape of the sample more clearly. The z-scale in deflection or amplitude is completely 
meaningless in terms of the sample structure. All it shows is how the tip deflected as it 
encountered sample topography. Nevertheless, the AFM images could not clearly show the 
topography of binding MENs to the surface of the bacteria. The 10 m scale AFM image 
does not show good MENs binding with the bacteria due to low resolution and sensitivity. 
Some bacteria like bacillus cereus may not interact strongly with the MENs. SEM images 
(Figure 16 through Figure 19) shows better clustering of particles with bacteria. 
 
Figure 12: AFM image of Pseudomonas aeruginosa in a medium without MENs (top two) 
and with MENs (bottom two) 
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Figure 13: Figure 3.5: AFM images of Escherichia coli in a medium without MENs (top 
two) and with MENs (bottom two) 
 
Figure 14: AFM images of Serratia marcescens in a medium without MENs (top two) and 
with MENs (bottom two).  
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Figure 15:  AFM images of Bacillus cereus in a medium without MENs (top two) and with 
MENs (bottom two).  
 
 The following SEM images Figure 16 through Figure 19 shows the clustering of 
MENs with the bacteria. The SEM images shown in Figure 16 through Figure 19 show the 
surface morphology of pseudomonas aeruginosa, escherichia coli, serratia marcescens, and 
bacillus cereus respectively. Top two figures are images of samples without nanoparticles 
while the bottom two are those with particles. The left side images are with the lower 
magnification and the right ones are with higher magnification (resolution) as shown in the 
labels at the bottom bars of each images.  
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Figure 16:  SEM images of pseudomonas aeruginosa without MENs (top two) and with MENs 
(bottom two) with different magnifications as shown in the label.  
 
 
Figure 17:  SEM images of escherichia coli without MENs (top two) and with MENs (bottom 
two) with different magnifications as shown in the label. 
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Figure 18:  SEM images of serratia marcescens without MENs (top two) and with MENs 
(bottom two) with different magnifications as shown in the label. 
 
 
Figure 19: Figure 3.11:  SEM images of bacillus cereus without MENs (top two) and with 
MENs (bottom two) with different magnifications as shown in the label. 
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4.3 Device optimization and bacterial measurement  
Device was designed as described in Chapter 3. The TEL cws 12-50 Advanced 
NMR/ESR System was optimized for the measurement of the bacterial sample. The 
absorbance of the sweep comes from the nanoparticles in the solution, meaning that a 
higher concentration of particles causes a greater absorbance (Figure 20 A). The optimal 
concentration for testing was selected to be 50 mg/ml as it resulted in the largest increase 
in absorption coupled with the smallest standard deviations.  The saline solution and 
bacterial cells give only a very weak background signal (Figure 20 B). 
 
Figure 20: NMR Absorbance. A) Nanoparticles in the solution determine the strength of the 
absorbance. B) Bacterial solutions have a very weak absorbance. 
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Figure 21: Pelleted 1 ml 1X bacteria, suspended in 20 l saline, added 20 l 50 mg/ml 
MENs. 
 
Next, the optimal phase for the field sweep was determined to be around 300 (Figure 22) 
and 297 was used for all readings. MENs were determined to the superior identifier of 
bacteria compared to magnetic nanoparticles and GMO-coated MENs (Figure 23).  
Frequency sweep results confirm patterns seen in the field sweep used (Figure 24). 
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Figure 23: MENs Provide Best Blind Differentiation. A) MENs being used to identify blinds. 
B) Traditional magnetic nanoparticles being used to identify blinds. C) GMO-coated MENs 
being used to identify blinds. 
 
Figure 22: Phase Optimization for MENs. A) MENs signal is strongest around a phase of 300. B) 
An example of a solution of bacteria with no MENs showing weak signal even at optimized 
settings. 
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Figure 24: Frequency Sweep. The field sweep data used is consistent with the frequency 
sweep data, but is not better for identifying bacterial blinds. 
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Figure 25:  A) Four bacterial species were used to demonstrate the unique MENs 
interacting properties of each. B) Blind identities were successfully determined using the 
reference: 1=S. marcescens, 2=B. cereus, 3=P. aeruginosa, 4=E. coli. 
 
Exploitation of intrinsic surface electromagnetic properties of biological organism 
works as a tool for biomedical signature and screening. 
The direct curves were analyzed to plot the signature curves of all four bacteria 
using moving average fit curve. The background curve due to MENs only were removed 
to get the signature of the bacteria only. Following are the eyeball comparison of each 
bacterium with MENs and corresponding signature curve. 
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Figure 26: Eyeball comparison of MENs and Bacillus Cereus 
 
 
Figure 27: Signature curve of Bacillus Cereus 
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Figure 28: Eyeball comparison of MENs and Serratia marcescens 
 
 
Figure 29: Signature curve of Serratia Marcescens 
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Figure 30: Eyeball comparison of MENs and Escherichia Coli 
 
 
Figure 31: Signature curve of Escherichia Coli 
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Figure 32: Eyeball comparison of MENs and Pseudomonas Aeruginosa 
 
 
Figure 33: Signature curve of Pseudomonas Aeruginosa 
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Figure 34: Signature curves of Bacillus Cereus (blue), Serratia Marcescens (red), 
Escherichia Coli (green), and Pseudomonas Aeruginosa (purple) 
 
Signature curves of all four bacteria are unique. Although the signature curve of 
Serratia Marcescens (Figure 29) and Escherichia Coli (Figure 31) seems quite close but 
they are clearly distinguishable. Optimization and proper calibration of MENs 
concentration, sample preparation, precise measurement and proper signal processing 
application design will eliminate the doubt if any. The experiments on bacterial sample 
shows that the MENs could be used not only to distinguished between their counterparts 
but also with other types of cells.  
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5. SIGNATURE IDENTIFICATION OF CANCER CELL LINES 
5.1 Background 
Rapid identification of cancer cells is vital for cancer prevention and treatment. 
Traditional techniques which rely on biochemical staining require a tedious sample 
preparation and are limited to a few biomarkers. A more advanced approach based on 
polymerase chain reaction (PCR) remains cost-ineffective in a small-clinic environment. 
Therefore, recently there has been increased interest in magnetic nanoparticle biosensing 
(MNB). Due to a new dimensionality provided by the presence of externally-controlled 
magnetic moments, MNB promises to enable high-specificity screening and fast diagnostic 
of pathogens.  Indeed, ideally one could envision an apparatus in which magnetic 
nanoparticles are used to couple intrinsic information related to single cells, e.g. the electric 
charge profile on the surface of a cell in a specific biological microenvironment, to an 
external magnetic device such as a nuclear magnetic resonance (NMR) system. However, 
the current progress in this area still remains relatively slow.  The main challenge is to 
couple magnetic nanoparticles to intrinsic information at the cellular or intra-cellular level 
with sufficiently high efficacy to be able to process the information with a magnetic system.  
While the system measures magnetic fields, the intrinsic cellular information is reflected 
in electric fields. It can be noted that in the cellular microenvironment, each cell structure, 
corresponding to a specific cancer type and a cancer progression stage, is characterized by 
a certain membrane surface morphology which in turn results in a signature electric-field 
configuration [65-67]. However, traditional purely magnetic nanoparticles wouldn’t be 
able to detect this complex electric-field configuration, unless they have electric charges. 
To address this problem, in lieu of the traditional magnetic nanoparticles, we have used a 
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type of multiferroic nanoparticles known as magnetoelectric nanoparticles (MENs). Unlike 
the traditional magnetic nanoparticles, MENs have both magnetic and electric dipole 
moments; in addition, these two different moments are correlated through the 
magnetoelectric (ME) effect. Due to the presence of an electric charge MENs preferentially 
attach to cell-specific sites, while due to the ME effect MENs allow to convert the intrinsic 
electric field information at the cellular level into a specific magnetic field pattern which 
in turn could be measured through a magnetic measurement setup such as an NMR system. 
Because each cell type has its own signature electric field distribution, such NMR 
measurements could be used to distinguish different cell types from each other at the intra-
cellular level.  
5.2 Sample preparation and cell culture  
MENs were prepared as described in chapter 2.3. CoFe2O4-BaTiO3 core shell 
MENs were prepared according to the following conventional procedure. As the first 
step, CoFe2O4 particles were prepared by the standard hydrothermal method, according 
to which 0.058 g of Co(NO3)2.6H20 and 0.16 g of Fe(NO3)3.9H20 were dissolved in 15 
ml of distilled water and 0.2 g of polyvinylpyrrolidone was dissolved in 5 ml of aqueous 
solution containing 0.9 g of sodium borohydride at 120°C for 12 hours. Then, a 
precursor solution of BaTiO3 was prepared by mixing 30 ml of aqueous solution 
containing 0.029 g of BaCO3 and 0.1 g of citric acid with 30 ml of ethanolic solution 
containing 1 g of citric acid and 0.048 ml of titanium (IV) isopropoxide. Coreshell 
CoFe2O4-BaTiO3 MENs were prepared by mixing 0.1 g of CoFe2O4 nanoparticles in the 
BaTiO3 precursor solution and the mixture was sonicated for 2 hrs. Once the 
CoFe2O4 nanoparticles were thoroughly dispersed, the mixture was dried on the hot plate 
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at 60°C overnight while being continuously stirred. The dried powder was heated to 
780°C for 5 hrs. in a furnace (CMF-1100) and cooled at 52°C per minute to obtain the 
coreshell MENs of ~30 nm diameter. The particles size distribution was measured using 
dynamic light scattering method (Malvern-Zetasizer). 
Three cancerous cell lines Skov-3 (Ovarian adenocarcinoma), U87-MG 
(Glioblastoma), MCF-7A (Breast adenocarcinoma) and two non-cancerous cell lines viz 
Brain Endothelial cells (Brain EC) and Rat smooth muscle endothelial cells (RSMC) were 
cultured at 37°C as per manufacturer’s instructions. For nanoparticle studies, cells were 
detached using 0.25 % trypsin solution, plated in 6 well plates and allowed to grow to 80 
% confluency. Magnetoelectric nanoparticles (MEN’s) were resuspended in cell culture 
media through sonication and were incubated for 30 minutes. MEN’s were added to each 
well at a concentration of 150 μg/ml and the cells were further incubated for 15 hours, to 
allow attachment of MEN’s with the cells. Effect of d.c magnetic field was studied by 
exposing the cells incubated with MEN’s to a magnet that was placed, at a distance, directly 
underneath the culture plate. The distance of magnet from cell culture plate needed to create 
100 Oe field was determined using a gauss meter. U87 -MG cells were exposed to field for 
6 hours after which the spectra was acquired whereas Brain EC’s and RSMC’s were 
exposed to field for 15 hours under MEN incubation. Additionally, all the cell lines were 
incubated with 150 μg/ml traditional MNP (CoFe2O4) for 15 hours with and without d.c. 
magnetic field. After the end of incubation period, the cells were washed with phosphate 
buffered saline (PBS) to remove particles not attached to cells. Cells were scraped from the 
bottom of plate and transferred to a 5 mm NMR tube. Continuous wave- 1H NMR readings 
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were obtained using a CWS 1250 NMR spectroscope. Sample placement, instrument 
parameters (B0, instrument phase,line-width) were carefully selected to ensure optimal 
signal to noise ratio. NMR spectra was collected at opposite phases (in our case these were 
107° and 297°). The spectra from cells with/without MEN’s was added with opposite phase 
signal of PBS to eliminate the solvent interference. The figures below are AFM images of 
endothelial cells (height on the left and phase on the right). Figure 35 (b) clearly shows that 
the MENs are inside the cells due to magnetic-electroporation when subjected to dc 
magnetic field as described earlier. 
 
Figure 35: AFM image pair of endothelial cells (z-height (left), phase (right)) 
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Figure 36: AFM image pair (z-height (left), phase (right)) of glioblastoma cells (a) without 
MENs, (b) with MENs 
 
5.3 Measurement of Cancer Cells 
In this study, MENs were integrated into media with different cancer cells and 
then their NMR spectrum was measured under equivalent conditions. 
 51 
 
 
Figure 37: CW-NMR spectra of cells without MENs for ovarian carcinoma cells SKOV-3, 
breast adenocarcinoma cells MCF-7 and glioblastoma cells U87-MG. 
 
Figure 37 shows continuous wave NMR curves for three cancer cell lines under 
study including glioblastoma cells, ovarian carcinoma cells SKOV-3, and breast 
adenocarcinoma cells MCF-7 without any nanoparticle being present in the media. The 
NMR signal is measured in the field sweep range from -2.5Gs to +2.5Gs and at a frequency 
of 14,000 kHz. It can be noted that the three cell lines don’t significantly differ from each 
other. 
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Figure 38: CW-NMR Spectra of (a) U87-MG, (b) SKOV-3, (c) MCF-7, and (d) Brain 
Endothelial Cells with traditional magnetic nanoparticles 
 
Figure 38 shows continuous wave NMR curves obtained by incubating three cancer 
cell lines (a) Glioblastoma, (b) SKOV-3, (c) MCF-7 and a non-cancerous healthy cell line 
(d) for 15 hours with traditional magnetic nanoparticles. Each set consists of three curves 
including spectra for cells only, cells incubated with MNPs without application of an 
external field, and cells incubated with MNPs under application of a 100-Oe d.c. field. The 
concentration of the nanoparticles in the media was approximately 150 μg/ml. Similar to 
the case without any nanoparticles, neither of the spectra i.e. cells only (solid line), cells 
with magnetic nanoparticles (broken lines) and cells with magnetic nanoparticles with 
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external magnetic field (dotted broken lines) for the four cell lines significantly differs from 
the corresponding cell line without MNs incubation as well as between each other.  
However, the above trend drastically changes if MENs are used instead of MNPs.  
 
Figure 39 CW-NMR spectra of cells incubated with MENs for (a) glioblastoma cells U87-
MG, (b) ovarian carcinoma cells SKOV-3, (c) breast adenocarcinoma cells MCF-7, and (d) 
normal brain endothelial cells 
 
Figure 39 shows CW-NMR spectra obtained by incubating the same three cancer 
cell lines and non-cancerous normal cell line for the same amount of time of 15 hours, with 
the only exception of having MENs instead of MNPs at the same concentration of 
approximately 150 μg/ml. According to these spectra, in great contrast to the traditional 
(a) (b) 
(c) (d) 
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MNPs, MENs significantly affects a NMR spectrum for each cancer cell type. The only 
exception is the non-cancerous endothelial cell line; as MNPs, MENs barely affected the 
spectrum. 
 
Figure 40: CW-NMR spectra of Glioblastoma, SKOV-3 and MCF-7 cells (broken lines as 
shown in the legend) with MENs and Glioblastoma cells without MENs (solid line) 
 
Figure 40 shows continuous wave NMR curves for the same three cancer cell lines 
incubated with MENs without field application under equivalent conditions. The 
concentration of the nanoparticles was approximately 150 μg/ml. Unlike the above case 
with the traditional MNs, the three cell lines Glioblastoma, SKOV-3 and MCF-7 
significantly differ from each other. It can be noted that the difference between the spectra 
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is not just quantitative but rather qualitative. Each cell type displays a distinguished set of 
peaks in its spectrum thus indicating an intrinsic interaction between MENs and cells. The 
spectra of Glioblastoma cells without any MENs (dark solid line) is provided for reference. 
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6. SIGNATURE ANALYSIS OF PROTHROMBIN 
6.1 Background 
As we described in chapter 2, it is imperative to understand the functionality of 
proteins in our body that plays a vital role for disease prevention and cure. There are many 
applications of nanotechnology on computer engineering, sensing, biology and medicines, 
pathogen detection etc. however not much is done specific to functionality of protein that 
cause diseases  [2-4,21-25]. Most of the nanomedicine technology rely on drug delivery 
through blood vessels so the toxicity of nanoparticles has been discussed but not its effect 
on the blood coagulation system [26-29]. Heart disease is the leading causes of death in the 
world. Ischaemic heart disease, stroke, lower respiratory infections and chronic obstructive 
lung disease have remained the top major killer diseases in recent years. It is critically 
important to control and monitor the Prothrombin Time (PT) in order to prevent from 
possible stroke or clot formation in blood vessels. We attempt to get the signature of 
prothrombin and its functionality using magnetoelectric nanoparticles. 
6.2 Prothrombin time and international normalized ratio 
Prothrombin time (PT) is a blood test that measures the time it takes for the plasma 
of your blood to clot. The measurement of prothrombin time depends on the reagent used 
in the laboratory. Unlike the standard laboratory test, viscoelastic method (VEM) is based 
on the whole blood coagulation available in real time at much faster turnaround time [68]. 
The prothrombin time is functional determination of the extrinsic (tissue factor) pathway 
of coagulation and is sensitive to the vitamin-K dependent clotting factors (factors II, VII, 
and X). Tissue factor (factor III) is a transmembrane protein that is widely expressed on 
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cells of non-vascular origin, which activates factor VII during the initiation of the extrinsic 
coagulation pathway.  
Since the prothrombin time varies according to the type of analytical system 
employed and the reagent used to perform the test, World Health Organization (WHO) 
introduced a standard way called International Normalized Ratio (INR) [69]. Each 
manufacturer assigns an International Sensitivity Index (ISI) for any tissue factor they 
manufacture as a reagent. The ISI value indicates how a particular batch of tissue factor 
compares to an international reference tissue factor. The INR of a patient is given by the 
following equation.  
𝐼𝑁𝑅 =  (
𝑃𝑃𝑇
𝑀𝑁𝑃𝑇
)
𝐼𝑆𝐼
 
Where, PPT is the Patient Prothrombin Time for the given reagent (ISI), and MNPT 
is the Mean Normal Prothrombin Time. 
The value of ISI is usually between 1 and 2. The INR of a healthy person is between 
0.8 and 1.1 while the physicians recommend it to be between 2 and 3 for therapeutic 
patients. 
Critically ill patients develop hemostatic abnormalities, ranging from isolated 
thrombocytopenia or prolonged global clotting tests to complex defects, such as 
disseminated intravascular coagulation. There are many causes of coagulation disorders 
depending the kind and condition of patients that require specific therapeutic or supportive 
management. In recent years, new insights into the pathogenesis and clinical management 
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of many coagulation defects in critically ill patients have been accumulated and optimized 
the diagnostic and therapeutic strategy [70]. 
The use of certain anticoagulant therapy in patients with cases of blood related heart 
disease, stroke and pulmonary arterial hypertension (PAH) has been controversial for 
decades [71-74]. In this study, with the approved IRB and consent with the patient (the 
researcher), we are performing an experiment in human subject using blood sample of 
patient with Pulmonary Artery Hypertension WHO group I. The results of Comparative, 
Prospective Registry of Newly Initiated Therapies for Pulmonary 
Hypertension (COMPERA) lend support to current recommendations for the use of 
anticoagulant therapy in patients with idiopathic PAH, but not in other forms of PAH [74-
76]. But, it is inevitable that the proper use of anticoagulant lowers the risk of heart failure 
provided that there are no other side effects.  
6.3  Sample Preparation 
MENs was prepared as described in chapter 2.3 with slight modification. CoFe2O4-
BaTiO3 core shell MENs were prepared according to the following conventional 
procedure. As the first step, CoFe2O4 particles were prepared by the standard hydrothermal 
method, according to which 0.058 g of Co(NO3)2.6H20 and 0.16 g of Fe(NO3)3.9H20 were 
dissolved in 15 ml of distilled water and 0.2 g of polyvinylpyrrolidone was dissolved in 5 
ml of aqueous solution containing 0.9 g of sodium borohydride at 120°C for 12 hours. 
Then, a precursor solution of BaTiO3 was prepared by mixing 30 ml of aqueous solution 
containing 0.029 g of BaCO3 and 0.1 g of citric acid with 30 ml of ethanolic solution 
containing 1 g of citric acid and 0.048 ml of titanium (IV) isopropoxide. Coreshell 
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CoFe2O4-BaTiO3 MENs were prepared by mixing 0.1 g of CoFe2O4 nanoparticles in the 
BaTiO3 precursor solution and the mixture was sonicated for 2 hrs. Once the CoFe2O4 
nanoparticles were thoroughly dispersed, the mixture was dried on the hot plate at 60°C 
overnight while being continuously stirred. The dried powder was heated to 780°C for 5 
hrs. in a furnace (CMF-1100) and cooled at 52°C per minute to obtain the coreshell MENs 
of ~30 nm diameter. The particles size distribution was measured using dynamic light 
scattering method (Malvern-Zetasizer). 
Blood sample was taken via finger prick from a patient of Pulmonary Arterial 
Hypertension, WHO Group I. The blood sample was taken in a pipette and gently 
transferred into a micro centrifuge tube containing MENs. Details are in the following 
chapter. 
6.4 Measurement of therapeutic blood  
 Blood consist of erythrocytes or red blood cells (RBC), leukocytes or white blood 
cells (WBC), and thrombocytes or platelets in plasma. It contains ferromagnetic materials 
especially in RBCs that is expected to interact with MENs. Most of the therapeutic drug 
used to control PAH is routed via blood so as the drug coated magnetoelectric nanoparticles 
(MENs). Interestingly, there is very little or none interaction of MENs on blood cells rather 
the experiment shows a significant effect on PT/ INR of the blood. Our objective is to 
analyze the interaction of MENs with the INR of therapeutic blood or other blood 
constituents especially the hemoglobin or hematocrit. With the approval of IRB protocol 
and consent from the Office of Research Integrity at FIU and all required trainings for 
 60 
 
Human Subject Research, therapeutic blood sample of a pulmonary arterial hypertension 
patient is taken for the study. 
Sample of blood from a PAH patient, New York Heart Association (NYHA) 
Functional Class III, was collected via finger prick. The measured INR of the blood was 
2.9, hemoglobin 18.9 gm/dL and hematocrit 58%. After treating with MENs of 
concentration 50 mg/mL, the INR increased to 4.1 however, the aftermath measurement of 
INR will not reflect the actual reading due to time exposed and concentration of the sample. 
The cougulometer may not function properly under such environment. It may indicate that 
the MENs has higher impact on the prothrombin time of blood. From the engineering 
prospective, experiments show a distinct signature of INR of therapeutic blood using 
MENs. In-depth analysis using molecular dynamics computational simulation will give the 
actual interaction mechanism of MENs on prothrombin. Currently, we are working to 
understand the underlying physics behind it. We tried to measure the INR with the lower 
concentration of MENs but failed to get the readings from cougulometer. A measured 
amount of citrate was added as a reversible anticoagulant to study its interaction with the 
nanoparticles using NMR. 
25 L of MENs Concentration 50 mg/mL was taken in a micro centrifuge tube with 
equal amount of therapeutic blood sample. Out of the sample, only one capillary was taken 
for NMR measurement. The CW-NMR spectrometer results are shown in the following 
graphs along with their signature curves. 
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Figure 40: Comparison of 10 nm MENs background (blue) and MENs with blood sample 
(red) 
 
 
Figure 41: Signature curve of 10 nm MENs with sample blood 
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Figure 42: Comparison of 30 nm MENs background (green), MENs with blood sample 
(blue) and MENs and blood sample with magnetization (red) 
 
 
Figure 43: Signature curve of 30 nm MENs with sample blood (blue) and MENs and sample 
blood with magnetization (red) 
Temporary magnetization of MENs (red) does effect the surface interaction with blood 
constituents but not significantly. 
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Figure 44: Comparison of 100 nm MENs background (blue), MENs with blood sample (red) 
and MENS and blood sample with magnetization (green) 
 
 
Figure 45: Signature curve of 100 nm MENs with sample blood (blue) and MENs and 
sample blood with magnetization (red) 
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As usual, X-axis in Gs and Y-axis is in arbitrary units. Figure 42 shows the efficacy 
of 30 nm MENs is greater than 10 nm (Figure 40) and 100 nm (Figure 44). Moreover, 
temporary magnetization does not have significant effect on the signature curve.  
For further study we chose 30nm MENs for the experiment due to its higher efficacy. 
The blood sample of therapeutic patient was taken by finger prick as in the previous 
experiment with measured INR 1.4. Next, 500 L of blood sample with the concentration 
of 500g/mL of MENs was taken in a NMR tube for measurement. Figure 46 shows the 
CW-NMR spectra of the blood sample (INR 1.4) with MENs. Sample placement, 
instrument parameter like B0, phase, and line width were carefully selected to ensure 
optimal signal to noise ratio. NMR spectra was collected at opposite phases 107° (blood 
with MENs) and 297° (background). The spectra from blood sample and MENs 
background was added with opposite phase signal to eliminate the possible solvent 
interference.  Field sweep was taken as 50 Gs with the frequency of 14,000 kHz. 
The INR of therapeutic patients varies depending on the physical activity, diet and 
various other factors so INR should be monitored such that it does not go down to around 
1 or up to around 4. The patient has been monitored with prescribed warfarin from 5 mg to 
7.5 mg per day since last several years. During regular checkup, at a point when the 
measured INR was 1.4, we took the blood sample and used for CW-NMR spectra. It is hard 
to keep diet (especially that interferes with vitamin K), exercise, supplemental oxygen, and 
other physical activities as normal for such an active patient so it is evident that the INR 
varies from time to time, therefore it needs to be monitored every 2 to 4 weeks and change 
the dose of warfarin accordingly. At some other time when the INR was 3.1, the blood 
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sample was taken again for measurement. Same as before, 500 L of blood sample with 
the concentration of 500 g/mL of MENs was taken in a NMR tube for measurement. 
Figure 47 shows the CW-NMR spectra of the blood sample (INR 3.1) with MENs. 
 
Figure 46: CW NMR Spectra of MENs with therapeutic blood of measured INR 1.4 
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Figure 47: CW NMR Spectra of MENs with therapeutic blood of measured INR 3.1 
 
Figure 48: CW-NMR Signature comparison of blood samples with measured INR 1.4 (blue) 
and 3.1 (red)  
Figure 48 shows that the signature of blood with lower INR (1.4) has greater intensity 
compare to the higher INR (3.1). Higher INR means thin blood where only few linkers 
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connecting kringles of prothrombin are active. Lower INR means dense blood that has high 
efficacy with the MENs so that we can see a significant peak in the graph. We are in the 
process of performing high resolution computational molecular dynamics simulation 
which may reveal the in-depth understanding of molecular mechanism of the system. 
6.5 Loess Method 
Most of the times we used Loess Method for the graph plot. There are several 
methods of smoothing the curves where moving averages is widely used by engineers when 
the variables are somewhat linearly distributed. We attempt to use an alternate way, mostly 
used by economists, called Loess method that strongly relates to non-parametric 
regression methods that combine multiple regression models in a k-nearest-neighbor-based 
meta-model. It can also be referred as LOcal regrESSion. In the loess method, weighted 
least squares are used to fit linear or quadratic functions of the predictors at the centers of 
neighborhoods. The radius of each neighborhood is chosen so that the neighborhood 
contains a specified percentage of the data points. The fraction of the data, called the 
smoothing parameter, in each local neighborhood controls the smoothness of the estimated 
surface. Data points in a given local neighborhood are weighted by a smooth decreasing 
function of their distance from the center of the neighborhood. SAS Analysis with the 
LOESS Procedure and dependent variable: yax is the intensity in arbitrary units.  
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Figure 49: Selection of smoothing parameter 
 
 
Figure 50: Figure 5.5: Curve fitting with smoothing parameter 0.053 
Smoothing parameter was found to be 0.053 from Figure 44. Figure 45 shows the 
best fit curve along with all the data points. 
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There is no significant interaction of blood constituents with magnetoelectric 
nanoparticles and is save to use in medical applications however, the PT- INR shows a 
significant increment which could in other way be beneficial for the patients in terms of 
anticoagulation therapy. 
6.6 Sample blood with MENs coated with GMO and EDC  
Another sample of blood from the same subject is collected via finger prick. The 
measured INR of the blood was 2.8, hemoglobin 19.0 gm/dL and hematocrit 58%. After 
treating with MENs of 2.5 mg, the Coagulation Meter showed the INR of 5.0. We must 
take into account that the time exposed to the blood after treating with MENs and the 
concentration of the blood have significant effect on INR and the coagulation meter will 
not reflect the actual value of PT or INR. The sample were treated MENs with GMO (GMO 
coated MENs sample preparation is discussed in Chapter 2.3.3) and with EDC separately. 
20uL of MENs Concentration 50mg/ml was taken in a micro centrifuge tube with 30uL of 
therapeutic blood sample.  
Since this study is only to find the interaction of two intermediate layers GMO and 
EDC, and the CW-NMR spectra is significantly different, here we have shown the direct 
plot without using Loess Method for signal smoothing. 
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Figure 51: Comparison of GMO and EDC coated 10 nm MENs with blood sample 
 
 
Figure 52: Comparison of GMO and EDC coated 100 nm MENs with blood sample 
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It is clear that the MENs can also acts as a contrasting agent and safe and non-toxic 
to human blood however, the computational Physics, molecular dynamics study will 
explain what triggers the molecular mechanism of blood constituents that results in 
increment of PT/ INR. The graphs Figure 51 and Figure 52 are CW-NMR spectra of GMO 
and EDC coated MENs of size 10nm and 100nm respectively. EDC coated MENs can 
better function for the signature of not only therapeutic blood sample but also with other 
biomolecular organisms. Currently, we are working with the Theoretical BioPhysics Group 
at the department of Physics at FIU to find out the underlying mechanism of molecular 
dynamics of prothrombin and nanoparticles interaction. 
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7. DISCUSSION 
The above experiments have clearly demonstrated that MENs are uniquely 
positioned to distinguish different cells and mircoorganisms from each other through 
identification of the samples’ electric-field properties at the subcellular level. In this study, 
MENs have been compared to traditional magnetic nanoparticles which don’t display any 
magnetoelectric effect and thus, unlike MENs, don’t produce any significant magnetic-
field-dependent electric field of their own. In other words, the experiments have proven 
that it is the presence of the unique ME effect which sets MENs apart from all the other 
nanoparticle types and turn them into a superior diagnostic tool. To demonstrate the 
fundamental nature of this diagnostic approach, three independent applications have been 
studied including identification of blood cells, bacteria, and cancer cells. All three types of 
aforementioned biomolecular organisms can have vital impacts on the modern state of 
disease prevention and life quality. To present the underlying story, this discussion will 
focus on one particular application: cancer cells. For example, in Chapter 5, the 
significance of the cancer related application cannot be underestimated. Again, only 
MENs, not traditional purely magnetic nanoparticles, could detect the fine NMR spectral 
features which originate from complex intrinsic charge configuration on the membrane 
surface of a specific cell type. 
The following back-of-the-envelope model could give an idea of the underlying 
physics of the diagnostic of cancer cells with MENs. When nanoparticles are placed in any 
cellular media, they bind to characteristic sites of the surface of cellular membrane such 
that the electric and chemical energy are minimized. Indeed, this could be seen in AFM 
images which clearly showed the nanoparticles “stick” to ruptured regions on the 
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glioblastoma cellular membrane surface. In contrast, the normal endothelial brain cell 
membranes displayed a relatively continuous rupture-free surface with no preferential 
binding sites. In case of a MEN, depending on the binding site, the intrinsic electric field 
is affected in a certain way due to the electrostatic and chemical bonds at this site. Because, 
unlike the traditional MNs, MENs have a non-zero electric dipole, the electrostatic bonds 
can be particularly strong. Previously, MENs were shown to acquire a non-zero surface 
charge due to the double-layer chemistry in the cellular microenvironment. Due to the ME 
effect the resulting change in the electric field would trigger a change in the magnetic 
moment of the nanoparticle, which in turn would induce a change of the local magnetic 
field at this particular location. Considering there are many nanoparticles, they would 
preferentially bind to all the characteristic sites and thus would change the net magnetic 
field in a very specific way depending on the cell type.  Thus, the effect could be quantified 
according to the following formulation.   
At each binding site, the NMR signal, e.g. the electromagnetic energy absorption, 
is generated when the following resonance condition is satisfied: h = MnHnet, where h is 
the Plank constant,   is the frequency of the electromagnetic wave, Mn is the magnetic 
moment due to the nuclear spin (in this study, the proton spin), Hnet is the net magnetic 
field at this location.  This local net field is made of the two contributions, the external field 
generated by the NMR magnets, H0, and the field due to the ME effect of MENs at the 
location, HME, respectively:  
Hnet = H0 + HME. 
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To a zeroth approximation, according to the ME dependence, in the vicinity of a 
nanoparticle, HME ~ MS = αE, where MS is the nanoparticle’s saturation magnetization, α is 
the ME coefficient, and E is the electric field in the vicinity of the nanoparticle. In turn, 
this electric field depends on the cell membrane morphology and the interaction between 
the binding site and the nanoparticle. Assuming an electric field, E, on the order of 1000 
V/cm, a ME coefficient, α, of 10 mVcm-1Oe-1, according to the ME expression, the induced 
local magnetic field, HME, could be on the order of 10 Oe, which would make a significant 
contribution to the NMR signal. The NMR bias field, H0, is on the order of 2,000 Oe. Here, 
it should be noted that the additional ME-induced field is very local, with a localization 
length defined by the MEN’s average size of approximately 30 nm. So, although the local 
induced fields are quite significant, the average effect in the relatively large NMR setup 
could be much smaller. According to this analysis, it can be seen that due to the ME effect, 
when an external magnetic field is swept in a 5-Oe range around the bias field during each 
NMR measurement, the measured spectrum should reflect contributions of MENs from 
different binding sites. That is the reason why we see a significant dependence on the cell 
type when MENs are placed into cancer media. Again, it can be noted that the traditional 
purely magnetic nanoparticles, which don’t display any ME effect, couldn’t provide this 
intrinsic contribution specific to each cell type, despite the fact that their saturation 
magnetization is almost two orders of magnitude higher than that for MENs. In a way, 
MENs allow to translate the intrinsic electric-field configuration on the cell membrane at 
the subcellular level into an easily measurable signature NMR signal specific to this 
particular cell type. 
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The same physics could be used to explain the observed MENs-affected NMR 
spectra in the other two applications under study, i.e., for blood cell and bacteria 
identification.  
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8. CONCLUSION 
MENs could be used to distinguished between different types of bacteria, viruses, 
blood cells, cancer cells and their normal counterparts at the subcellular level.  
The above experiments on bacteria, cancer cells, and prothrombin clearly showed 
that MENs could be used not only to distinguish between the organisms from their normal 
counterparts but also to identify different organisms. In other words, the experiment on 
cancer cells showed that MENs could be used not only to distinguish between cancer cells 
from their normal counterparts but also to identify different cancer cell lines. Different cells 
have different surface topography with different binding sites for nanoparticles. In addition, 
the surface morphology depends on the cell progression. In other words, the NMR signal 
modified by MENs in the cell media is complex and made of several components. The 
nanoparticles can be found on the cell membrane surface as well as inside the cell, as 
confirmed through AFM analysis. An important observation is the fact only MENs, due to 
the ME effect, could be used to provide such a signature identification at the subcellular 
level. For comparison, traditional magnetic nanoparticles with no ME effect couldn’t 
provide such a precise diagnostic capability.  
Optimization and proper calibration of MENs concentration, sample preparation, 
precise measurement and proper signal processing application design will further enhance 
the signature identification of biomolecules. It has been proven that exploitation of intrinsic 
surface electromagnetic properties of biological organism and utilization of the nuclear 
magnetic resonance property can enable a cost effective and portable tool for biomedical 
signature and screening.  
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9. FUTURE WORK 
Experimentally, we have shown the clustering of microorganisms with MENs and 
their magnetoelectric contribution leading to signature identification. We are working on 
the study of molecular interaction using free software called VMD (Visual Molecular 
Dynamics) and NAMD (Nanoscale Molecular Dynamics) simulation that can lead to an 
in-depth analysis of MENs interaction with microorganisms. Recently, theoretical 
biophysics group at FIU showed that Ebola virus protein hexamer enhances the clustering 
of certain lipids in the plasma membrane [77]. IBM group has shown the potential 
interference of protein-protein interactions by graphene using computation molecular 
dynamics [78].  Nobody has done any theoretical research on MENs interaction with 
protein. We are using PDB (Protein Data Bank) file of prothrombin to study the interaction 
of MENs that can not only potentially explain our experimental result but also lead to 
possible treatment of blood related diseases. 
Moreover, we move forward from the use of magnetoelectric nanoparticles; 
paradigm shift from diagnostics to treatment. With the approved IACUC, we are currently 
working on in-vivo experiment of MENs for PH in mouse model. The arteries are complex 
in structure; however, we take a simple mechanical model and try to get the stiff PASMC 
back into normal. 
The modal is based on the Navier-Stokes equation for incompressible flow, 
𝜌 (
𝜕𝑣
𝜕𝑡
+ 𝑣. ∇𝑣) = −∇p + μ∇2𝑣 + 𝑓. Continuity equation for incompressible blood flow, 
∇. 𝑣 = 0 ( being constant) 
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Finite Element Method (FEM) simulation modelling was performed to study the 
variation of blood pressure due to stiffness of arteries. 
 
Figure 53: Deformation of arteries with neo-hookean coefficient. 
 
The graph in Figure 53 shows that the stiff arteries get less relaxed due to the pressure of 
blood compared to normal arteries. 
The magnetic dipole moment of PASMC depends on the magnetic orientation of the cell’s 
magnetic dipole 𝑑~𝛼′𝐻 and ℎ~
1
𝑑𝑡
~
1
(𝛼′𝐻)𝑡
, (proposed Khanal’s equation) where the value 
of t ranges from 0.3 to 2.  
Furthermore, most of the effective vasodilators, specially prostacyclin (PGI2) 
synthetic analogues have very low half life in plasma. Knowing the fact that less than 1% 
of current PH drugs is delivered to the targeted diseased PASMC. Our approach is to 
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deliver 100% of the drug to specific cells. Firstly, we perform in vitro experiments to bind 
such PH drugs in the smart nanoparticles for targeted delivery on diseased cells. We 
approach to pre-program the self-triggering mechanism via defining the MENs saturation 
magnetization and the magneto-electric (ME) coefficient through a fabrication process or 
via application of an external magnetic field.  
 
Figure 54: Schematic diagram of drug loaded MENs with critical field entering PASMC 
 
Figure 54 depicts the MEN as field controlled nano-electroporation sites to let the 
drug pass through the endothelial cells and delivered to PASMC. At the threshold field Hth, 
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the drug loaded MEN enters PASMC, and as the field increases further, the release of the 
drug from MEN is initiated.  
In collaboration with theoretical biophysics research group at the department of 
physics at FIU and Miami Cardiovascular Institute, Baptist Health South Florida, we are 
in process of working on finding a new drug on MENs that can potentially cure PAH.  
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